​

Protagenic Therapeutics Stock (NASDAQ:PTIX)

OwnershipFinancialsChart

Previous Close

$0.22

52W Range

$0.14 - $6.20

50D Avg

$0.42

200D Avg

$1.02

Market Cap

$391.00K

Avg Vol (3M)

$7.34K

Beta

1.01

Div Yield

$479.75M

PTIX Company Profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1

IPO Date

Apr 27, 2021

Website

PTIX Performance

PTIX Financial Summary

Dec 24Dec 23Dec 22
Revenue---
Operating Income$-5.70M$-4.53M$-3.56M
Net Income$-5.53M$-5.00M$-3.60M
EBITDA$-5.70M$-4.50M$-3.42M
Basic EPS$-1.13$-1.15$-0.83
Diluted EPS$-1.13$-1.15$-0.83

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 23Apr 01, 24 | 4:30 PM

Peer Comparison

TickerCompany
PBMPsyence Biomedical Ltd.
CARMCarisma Therapeutics, Inc.
SPRCSciSparc Ltd.
ARTLArtelo Biosciences, Inc.
GTBPGT Biopharma, Inc.
REVBRevelation Biosciences, Inc.
SLXNSilexion Therapeutics Ltd.
INDPIndaptus Therapeutics, Inc.